Navigation Links
LA BioMed to honor Emil D. Kakkis, M.D., Ph.D., and LA County Supervisor Don Knabe
Date:9/28/2009

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) will honor Los Angeles County Supervisor Don Knabe and Emil D. Kakkis, MD, PhD, founder and president of Kakkis EveryLife Foundation, as its "Spirit of Excellence" award winners at its annual Discovery Gala Nov. 6 at the Terranea Resort in Rancho Palos Verdes.

"We are so pleased to be honoring two outstanding men for the excellence each represents in his chosen field," said LA BioMed President and CEO David I. Meyer, PhD. "Dr. Kakkis is a renowned researcher who led a team of gifted scientists in developing a breakthrough treatment a life-threatening inherited disorder known as MPS I or Hurler-Scheie disease. Supervisor Knabe has excelled at serving the community and his constituents for more than a decade, and he's been a strong supporter of LA BioMed."

Dr. Kakkis is best known for his work over the last 18 years to develop novel treatments for neglected rare disorders. He began his work in a research bungalow at LA BioMed at Harbor-UCLA Medical Center, working to develop an enzyme replacement therapy (Aldurazyme) for the rare disorder, MPS I.

Supervisor Knabe was first elected to the Los Angeles County Board of Supervisors in November of 1996 and was overwhelmingly re-elected in 2000, 2004 and 2008. Supervisor Knabe represents the Fourth District, which is a uniquely diverse area that is home to more than 2 million residents. He has been a tremendous advocate for LA BioMed and Harbor-UCLA Medical Center.

"The theme of this year's Gala, 'The Art of Discovery,' celebrates the creative spirit, which is the essence of biomedical research and discovery," said Gala Co-Chair Jennifer Laity. "In bringing together our researchers and showcasing their discoveries, in the company of talented local artists and craftsmen, the Gala celebrates LA BioMed's innovative biomedical research, its continuing contributions to the community and the training i
'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...often had the same kind of trouble in medical scho... disciplined by state medical boards were three ti...ional behavior while in medical school than those ...ctive concepts such as personal behavior or profes...
...be focused on the bird flu pandemic that is expect...lready taken a toll of 25 million lives in as many... attention. The AIDS program does not even have th...he developed world is more concerned with the bird...
...s for Christmas turkeys in the wake of fears of bi...topped the British and the Germans from buying the...try sources. In France, bulk buyers such as r...re not stocking enough poultry. France, home o...
...e usage of two drugs in a rare medical trail. Thes...f AIDS. // They are anti-retroviral drugs which...ogether is not been reviewed. These drugs are unap... months earlier and a patient died. So the clinici...
...nation in the words of Dr Johnson, "CLARET is the ...to be a hero must drink brandy." It underline...g 30ml of brandy has the same antioxidant potentia... of Gordon Troup from Monash's school of physics, ...
...d by the pharmaceutical company Pfizer in 30 diffe...n men are believed to suffer from erectile dysfunc...s to approximately 10 to 15 % of the market within...he Indian Pharmaceutical market have been held res...
Other Medicine News:Health News:Bad professional behavior dates back to medical school 2Health News:Bad professional behavior dates back to medical school 3Health News:Flu Pandemic Gets More Attention Than AIDS 2Health News:Christmas turkey? Anyone? 2Health News:Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients. 2Health News:Erectile Dysfunction Drug Viagra Launched In India By Pfizer 2
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVa...sedondevelopingproductsforminimallydisruptivesurgi...ostaconferencecallonMonday,November30,2009,at5:30p...ntissuesrelativetoreimbursementfortheCompany,sprod...ashortquestionandanswersession.Thedial-innumbersar...
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:...yearsfollowinganautoaccident,wasactuallyfullyconsc...orningAmericasegment.TheDynaVoxEyeMaxwasfeaturedin...meandotherconditionscanunlockcommunication. ,, ...ableonlineat www.dynavoxtech.com ,, WHO:...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2EnVivo to Share Results of its EVP 6124 Phase Ib IIa Trial at The International Conference on Alzheimers Disease 50909 1EnVivo to Share Results of its EVP 6124 Phase Ib IIa Trial at The International Conference on Alzheimers Disease 50909 2LifeNet Health Launches Sports Medicine Bio Implants 50907 1LifeNet Health Launches Sports Medicine Bio Implants 50907 2Johnson 26 Johnson to Host Analyst Conference Call on Second Quarter Results 50905 1
... Highlights Oral Xeloda versus Standard Infusional... Colorectal Cancers -, NUTLEY, N.J., Jan. 24 Roc...volving its oral chemotherapy Xeloda(R) have been,...inal Cancers Symposium in,Orlando, Fla., from Jan....S. data offer additional knowledge,about Xeloda. T...
...dation based on study results demonstrating surviv... to standard therapy, -- First study to show surv...ULDER, Colo., Jan. 24 Pharmion Corporation,(Nasda...ines Agency (EMEA),has issued a positive opinion t...r use in combination with melphalan and prednisone...
Other Medicine Technology:Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 2Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 3Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 2Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 3Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 4Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 5Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 6
BLF21 Single Channel
Oxyflo 2000
Multi Dop X4
Multi Dop L1
Medicine Products: